Top Stock Reports for Mastercard, Procter & Gamble & Novartis

Zacks12-13

Thursday, December 12, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491354677?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RtpnW0ot1lxivHZsw4m7IA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ce2e9f546df6c71991dbe2a616a08054","is_english":true,"pubTime":"2024-12-13 04:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2491354677","market":"us","top_or_hot":-1,"title":"Top Stock Reports for Mastercard, Procter & Gamble & Novartis","media":"Zacks","content":"<div>\n<p>Thursday, December 12, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-stock-reports-mastercard-procter-200000981.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Stock Reports for Mastercard, Procter & Gamble & Novartis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Stock Reports for Mastercard, Procter & Gamble & Novartis\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-13 04:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/top-stock-reports-mastercard-procter-200000981.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thursday, December 12, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-stock-reports-mastercard-procter-200000981.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRP","symbol_name":"TC Energy","start_time":0,"source_url":"https://finance.yahoo.com/news/top-stock-reports-mastercard-procter-200000981.html","article_id":"2491354677","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RtpnW0ot1lxivHZsw4m7IA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ce2e9f546df6c71991dbe2a616a08054"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491354677","pubTimestamp":1734033600,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Mastercardshares outperformed Visa shares over the past year , but lagged the broader market over the same time period .The Zacks analyst notes that numerous acquisitions are helping Mastercard to grow addressable markets and drive new revenue streams. Mastercard expects low-teens net revenue growth in the fourth quarter of 2024. The accelerated adoption of digital and contactless solutions is providing an opportunity for its business to expedite its shift to the digital mode.However, steep operating expenses might stress its margins in the future. High rebates and incentives may weigh on net revenues.However, Novartis maintains strong momentum on the back of a strong and diverse portfolio with drugs like Entresto, Kesimpta, Kisqali, Cosentyx, Pluvicto and Leqvio. The label expansion of Kisqali further fuels sales of this drug. Approval of new drugs and label expansion of existing drugs should aid.IDT’s shares have outperformed the Zacks Diversified Communication Services industry over","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRP":"TC Energy","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","IDT":"万威","BK4115":"综合电信业务","SG9999014542.SGD":"United Income Focus Trust Acc SGD","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","SONY":"索尼","ENB":"安桥","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","ALC":"爱尔康","NVS":"诺华","ZM":"Zoom","LDOS":"Leidos Holdings Inc","MA":"万事达","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","LU1917777945.USD":"安联专题基金Cl AT Acc","MSI":"摩托罗拉解决方案","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","MCK":"麦克森药物批发","SKYW":"西空航空","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","HOG":"哈雷戴维森","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","BK4567":"ESG概念","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0823421333.USD":"BNP PARIBAS DISRUPTIVE TECHNOLOGY \"C\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","KEY":"KeyCorp","DOV":"美国都福集团","LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","BK4207":"综合性银行","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","PG":"宝洁","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","GSIT":"广船国际技术","LU2322448957.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMG\" (HKD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","PLAY":"Dave & Buster","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","BK4589":"SVB概念"},"translate_title":"万事达卡、宝洁和诺华的热门股票报告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZM":1,"ALC":1,"LDOS":1,"KEY":1,"MA":1,"MCK":1,"MSI":1,"NVS":1,"PG":1,"PLAY":1,"IDT":1,"HOG":1,"GSIT":1,"DOV":1,"SKYW":1,"SONY":1,"TRP":1,"ENB":0.9},"content_text":"Thursday, December 12, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), The Procter & Gamble Company (PG) and Novartis AG (NVS), as well as two micro-cap stocks, IDT Corporation (IDT) and GSI Technology, Inc. (GSIT). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>\nMastercard shares outperformed Visa shares over the past year (+25.6% vs. +19.9%), but lagged the broader market over the same time period (+25.6% vs. +30.5%). The Zacks analyst notes that numerous acquisitions are helping Mastercard to grow addressable markets and drive new revenue streams. Mastercard expects low-teens net revenue growth in the fourth quarter of 2024. The accelerated adoption of digital and contactless solutions is providing an opportunity for its business to expedite its shift to the digital mode.\nHowever, steep operating expenses might stress its margins in the future. High rebates and incentives may weigh on net revenues.\n(You can read the full research report on Mastercard here >>>)\nProcter & Gamble shares have outperformed the Zacks Consumer Products - Staples industry over the past year (+14.9% vs. +10.1%). The Zacks analyst believes that the company has been gaining from a strategy that focuses on sustainability and adaptability, responding to the evolving demands of consumers and society. It has been focused on productivity and cost-saving plans to boost margins.\nYet, PG has been witnessing headwinds related to the market issues in Greater China, geopolitical tensions, and financial impacts from currency volatility.\n(You can read the full research report on Procter & Gamble here >>>)\nShares of Novartis have underperformed the Zacks  Large Cap Pharmaceuticals industry over the past two years (+8.7% vs. +15.0%). Per the Zacks analyst, the loss of patent protection for some of the key drugs in Novartis’ portfolio is a concern. Gleevec/Glivec, Diovan and Exforge face continued and increasing generic competition in major markets. Novartis has continued to suffer legal setbacks in its attempt to block the entry of a generic version of its blockbuster heart drug Entresto. The company has also suffered quite a few pipeline setbacks.\nHowever, Novartis maintains strong momentum on the back of a strong and diverse portfolio with drugs like Entresto, Kesimpta, Kisqali, Cosentyx, Pluvicto and Leqvio. The label expansion of Kisqali further fuels sales of this drug. Approval of new drugs and label expansion of existing drugs should aid.\n(You can read the full research report on Novartis here >>>)\nIDT’s shares have outperformed the Zacks Diversified Communication Services industry over the last six months (+40.5% vs. -1.5%). The Zacks analyst believes that IDT's growth strategy centers on high-growth segments like NRS, BOSS Money, and net2phone, which are expanding in digital payments, international remittances, and cloud communications. IDT's cost controls boosted profitability. Positioned in digital and cashless payment trends, IDT leverages BOSS Money and NRS's strong merchant network.\nYet, competition and regulatory compliance pressures may impact profitability. The legacy communications segment's decline and fintech competition pose challenges for sustaining revenue growth. Other challenges include regulatory pressures, currency volatility and scaling investments.\n(You can read the full research report on IDT here >>>)\nGSI Tech’s shares have outperformed the Zacks Computer – Storage Devices industry over the last six months (+4.1% vs. -26.5%). The Zacks analyst believes that introduction of Gemini-I APU servers has boosted the company’s prospects. Expansion into government contracts through SBIR initiatives diversifies revenue and enhances defense sector credibility. The company's next development, Gemini-II, aims to enhance data processing efficiency, promising significant market penetration.\nYet, challenges arise from a significant drop in core SigmaQuad sales and dependency on major customers like Nokia, introducing revenue volatility. Competitive pressures in the rapidly evolving HPC market necessitate continuous innovation.\n(You can read the full research report on GSI Tech here >>>)\nOther noteworthy reports we are featuring today include Sony Group Corporation (SONY), Enbridge Inc. (ENB) and Motorola Solutions, Inc. (MSI).Director of ResearchSheraz MianNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>\nToday's Must Read\nKisqali, Pluvicto Drive Novartis (NVS) Amid Competition\nStrong Cross-Border Volumes Aid Mastercard (MA) Amid High Costs\nP&G's (PG) Productivity & Cost Savings Plan to Aid Margins\nFeatured Reports\nTC Energy (TRP) to Capitalize on Growing Natural Gas DemandThe Zacks analyst believes TC Energy is uniquely positioned to capitalize on the growing North American natural gas demand, driven by LNG exports and the electricity needs of AI data centers.\nEnbridge (ENB) Gains From Long-term Transportation ContractsEnbridge generates stable fee-based revenues from its long-term, low-risk oil and gas transportation contracts. Yet, its significant debt exposure concerns the Zacks analyst.\nSolid Music & G&NS Sales Boost SONY Amid Weak Hardware SalesPer the Zacks analyst, strength in the Game & Network Services, notably software sales and Music units is driving Sony's performance. Reduced demand for hardware and mobile sensors are concerning.\nDiverse Product Portfolio, Strategic Alliances Aid Motorola Solutions Per the Zacks analyst, Motorola is poised for solid growth in video security, command center software and land mobile radio services led by healthy demand trends and a holistic growth focus.\nSurgical Sales Rebound, New Product Launches Aid Alcon (ALC)The Zacks analyst is optimistic about consistent share gains and strong global ATIOL penetrations within Alcon's Surgical business. New product launches aid growth.\nDemand for Specialty Products Driving McKesson (MCK) ProspectsPer the Zacks analyst, McKesson's distribution segment will continue to benefit from higher volume of specialty products coupled with price rise. Rising demand for extended and primary care buoys well\nLoans, Restructuring Aid KeyCorp (KEY), Asset Quality AilsPer the Zacks analyst, decent loan demand, restructuring initiatives, and relatively high rates will support Keycorp's financials. Yet, elevated expenses and weak asset quality are headwinds.\nNew Upgrades\nExpanding Clientele, Hybrid-Working Solutions Aids Zoom (ZM)Per the Zacks analyst, Zoom is benefiting from solid adoption of hybrid-working solutions like Zoom Phone and expanding subscriber base driven by the need for digital transformation among enterprises.\nFavorable Budget, Solid Contract Wins Aid Leidos (LDOS)Per the Zacks analyst, increasing budgetary revisions by the U.S. administration should boost Leidos' growth. Steady contract wins also bolster this stock's revenue prospects.\nSkyWest (SKYW) Benefits From Improving Air-Travel DemandThe Zacks Analyst is impressed with the fact that increased air-travel demand is helping SkyWest carry more passengers and witness more revenues.\nNew Downgrades\nLower Volumes & Elevated Costs Ail Dover's (DOV) PerformancePer the Zacks analyst, lower business volumes will impact Dover's performance in the upcoming quarters. Elevated costs and supply-chain issues will continue to be headwinds.\nExpected Decline in Shipment, Rising Capex Ail Harley (HOG)Per the Zacks analyst, an anticipated decline in wholesale shipment in 2024 is likely to hurt Harley's revenue growth. Rising capital requirement is also a concern.\nDave & Buster's (PLAY) Hurt By Dismal Comparable Store SalesPer the Zacks analyst, Dave & Buster's performance continues to hurt by dismal comparable store sales. During third-quarter fiscal 2024, comps declined 7.7% year over year.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nNovartis AG (NVS) : Free Stock Analysis Report\nMastercard Incorporated (MA) : Free Stock Analysis Report\nProcter & Gamble Company (The) (PG) : Free Stock Analysis Report\nEnbridge Inc (ENB) : Free Stock Analysis Report\nMotorola Solutions, Inc. (MSI) : Free Stock Analysis Report\nSony Corporation (SONY) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491354677"}